1. Home
  2. UPC vs SLRX Comparison

UPC vs SLRX Comparison

Compare UPC & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • SLRX
  • Stock Information
  • Founded
  • UPC 1998
  • SLRX N/A
  • Country
  • UPC China
  • SLRX United States
  • Employees
  • UPC 225
  • SLRX N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • SLRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • SLRX Health Care
  • Exchange
  • UPC Nasdaq
  • SLRX Nasdaq
  • Market Cap
  • UPC 1.9M
  • SLRX 2.1M
  • IPO Year
  • UPC 2021
  • SLRX N/A
  • Fundamental
  • Price
  • UPC $0.13
  • SLRX $1.05
  • Analyst Decision
  • UPC
  • SLRX
  • Analyst Count
  • UPC 0
  • SLRX 0
  • Target Price
  • UPC N/A
  • SLRX N/A
  • AVG Volume (30 Days)
  • UPC 803.8K
  • SLRX 194.6K
  • Earning Date
  • UPC 01-01-0001
  • SLRX 03-21-2025
  • Dividend Yield
  • UPC N/A
  • SLRX N/A
  • EPS Growth
  • UPC N/A
  • SLRX N/A
  • EPS
  • UPC N/A
  • SLRX N/A
  • Revenue
  • UPC $26,725,919.00
  • SLRX N/A
  • Revenue This Year
  • UPC N/A
  • SLRX N/A
  • Revenue Next Year
  • UPC N/A
  • SLRX N/A
  • P/E Ratio
  • UPC N/A
  • SLRX N/A
  • Revenue Growth
  • UPC N/A
  • SLRX N/A
  • 52 Week Low
  • UPC $0.12
  • SLRX $0.91
  • 52 Week High
  • UPC $4.32
  • SLRX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • UPC 31.23
  • SLRX 33.94
  • Support Level
  • UPC $0.11
  • SLRX $0.95
  • Resistance Level
  • UPC $0.17
  • SLRX $1.08
  • Average True Range (ATR)
  • UPC 0.03
  • SLRX 0.17
  • MACD
  • UPC 0.02
  • SLRX -0.02
  • Stochastic Oscillator
  • UPC 9.66
  • SLRX 18.85

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Share on Social Networks: